Key terms
About QGEN
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest QGEN news
Apr 17
10:35am ET
Bank of America Securities Reaffirms Their Buy Rating on Qiagen (QGEN)
Apr 17
4:10am ET
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Innate Pharma SA (OtherIPHYF) and Neumora Therapeutics, Inc. (NMRA)
Apr 16
7:05am ET
Deutsche Bank Remains a Buy on Qiagen (QGEN)
Mar 01
3:25am ET
UBS Sticks to Their Hold Rating for Qiagen (QGEN)
Feb 16
9:37am ET
UPS upgraded, Nike downgraded: Wall Street’s top analyst calls
Feb 16
7:52am ET
Qiagen upgraded to Overweight from Equal Weight at Morgan Stanley
Feb 16
3:05am ET
Berenberg Bank Reaffirms Their Buy Rating on Qiagen (QGEN)
Feb 15
9:25pm ET
Goldman Sachs Reaffirms Their Sell Rating on Qiagen (QGEN)
Feb 09
12:57am ET
Buy Recommendation for Qiagen: Anticipated Growth and Strategic Underpromise
Feb 08
8:35pm ET
Kepler Capital Keeps Their Hold Rating on Qiagen (QGEN)
Feb 08
6:38am ET
Qiagen price target lowered to $60 from $61.86 at Citi
Feb 08
5:18am ET
Maintaining Buy on Qiagen: Strong Q4 Performance and Positive Long-Term Outlook
Feb 07
9:40pm ET
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Ascendis Pharma (ASND)
Feb 07
8:41am ET
UBS Remains a Hold on Qiagen (QGEN)
Feb 07
8:41am ET
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Qiagen (QGEN) and Inspire Medical Systems (INSP)
Feb 07
8:40am ET
Stifel Nicolaus Sticks to Their Hold Rating for Qiagen (QGEN)
Feb 07
8:21am ET
Analysts’ Top Healthcare Picks: Amgen (AMGN), Qiagen (QGEN)
Feb 07
7:10am ET
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Inspire Medical Systems (INSP) and Gilead Sciences (GILD)
Feb 06
9:30pm ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Qiagen (QGEN) and Waters (WAT)
Feb 06
4:18pm ET
Qiagen reports Q4 EPS 55c consensus 55c
Feb 06
9:48am ET
Qiagen rumor highlighted again in Betaville blog
Jan 31
1:18pm ET
Qiagen price target lowered to EUR 47 from EUR 48.45 at Morgan Stanley
Jan 26
8:50pm ET
Analysts Conflicted on These Healthcare Names: HCA Healthcare (HCA), Thermo Fisher (TMO) and Qiagen (QGEN)
Jan 26
8:10am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF) and Qiagen (QGEN)
Jan 25
10:02am ET
Qiagen partners with Penn State to advance microbiome sciences
Jan 18
4:16pm ET
Qiagen announces details for completion of share repurchase up to $300M
Jan 18
10:05am ET
Berenberg Bank Remains a Buy on Qiagen (QGEN)
No recent press releases are available for QGEN
QGEN Financials
Key terms
Ad Feedback
QGEN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
QGEN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range